IMotions A/S
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
EBITDA | <1m | <1m | <1m | <1m | <1m | (1.3m) | - |
Profit | <1m | <1m | <1m | <1m | (<1m) | (1.4m) | <1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.6m | Early VC | ||
$2.7m | Early VC | ||
$46.6m Valuation: $46.6m 53.6x EV/LTM EBITDA | Acquisition | ||
Total Funding | €3.9m |
Recent News about IMotions A/S
EditiMotions operates as a leading emotion recognition software platform, specializing in the integration of multiple biosensor hardware to quantify engagement and emotional responses. The company serves a diverse range of clients including academic institutions, medical researchers, and corporate entities interested in human behavior analysis. Operating in the global market, iMotions' business model revolves around providing a comprehensive software solution that synchronizes data from various biometric sensors such as Eye Tracking, EDA GSR, EEG, ECG, and Facial Expression Analysis. This integration allows for a seamless and consistent data collection process, enhancing the validity of human behavior research. Revenue is generated through software licensing, subscription models, and customized solutions for specific research needs. The platform is designed to be versatile, supporting a wide array of applications from psychology and cognitive processes to machine learning and VR therapy. By joining forces with Smart Eye, iMotions aims to further humanize technology, making it more intuitive and responsive to human emotional states.
Keywords: emotion recognition, biosensors, human behavior, Eye Tracking, EEG, EDA GSR, Facial Expression Analysis, cognitive research, medical research, VR therapy, machine learning.